Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020

SELL
$104.32 - $195.28 $1.8 Million - $3.38 Million
-17,287 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$144.16 - $172.9 $1,729 - $2,074
12 Added 0.07%
17,287 $2.99 Million
Q1 2019

May 14, 2019

SELL
$123.7 - $156.3 $1,484 - $1,875
-12 Reduced 0.07%
17,275 $2.64 Million
Q4 2018

Feb 14, 2019

SELL
$120.82 - $174.09 $495,362 - $713,769
-4,100 Reduced 19.17%
17,287 $2.19 Million
Q3 2018

Nov 14, 2018

BUY
$167.67 - $188.27 $25,150 - $28,240
150 Added 0.71%
21,387 $3.71 Million
Q2 2018

Aug 14, 2018

SELL
$160.33 - $189.41 $8,016 - $9,470
-50 Reduced 0.23%
21,237 $3.81 Million
Q1 2018

May 14, 2018

BUY
$161.53 - $178.11 $339,213 - $374,031
2,100 Added 10.94%
21,287 $3.44 Million
Q3 2017

Nov 14, 2017

BUY
$149.47 - $160.56 $2.87 Million - $3.08 Million
19,187
19,187 $2.9 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $21.1B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Stone Run Capital, LLC Portfolio

Follow Stone Run Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stone Run Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stone Run Capital, LLC with notifications on news.